U.S. Markets closed
  • S&P 500

    4,395.64
    +41.45 (+0.95%)
     
  • Dow 30

    34,258.32
    +338.48 (+1.00%)
     
  • Nasdaq

    14,896.85
    +150.45 (+1.02%)
     
  • Russell 2000

    2,218.56
    +32.38 (+1.48%)
     
  • Gold

    1,768.40
    -9.80 (-0.55%)
     
  • Silver

    23.03
    +0.46 (+2.05%)
     
  • EUR/USD

    1.1696
    -0.0034 (-0.2924%)
     
  • 10-Yr Bond

    1.3360
    +0.0120 (+0.91%)
     
  • Vix

    20.87
    -3.49 (-14.33%)
     
  • GBP/USD

    1.3619
    -0.0045 (-0.3282%)
     
  • USD/JPY

    109.7800
    +0.5600 (+0.5127%)
     
  • BTC-USD

    42,654.92
    -272.68 (-0.64%)
     
  • CMC Crypto 200

    1,089.55
    +49.07 (+4.72%)
     
  • FTSE 100

    7,083.37
    +102.39 (+1.47%)
     
  • Nikkei 225

    29,639.40
    -200.31 (-0.67%)
     

Arena Pharmaceuticals Inc (ARNA) President and CEO Amit Munshi Sold $1.1 million of Shares

·1 min read

- By insider

President and CEO of Arena Pharmaceuticals Inc (30-Year Financial, Insider Trades) Amit Munshi (insider trades) sold 14,877 shares of ARNA on 01/12/2021 at an average price of $75.12 a share. The total sale was $1.1 million.


Arena Pharmaceuticals Inc is a biopharmaceutical company. The Company is engaged in discovering, developing and commercializing novel drugs that target G protein-coupled receptors, or GPCRs, to address unmet medical needs. Arena Pharmaceuticals Inc has a market cap of $4.69 billion; its shares were traded at around $80.560000 with and P/S ratio of 1278.75. GuruFocus has detected 3 severe warning signs with Arena Pharmaceuticals Inc. .

CEO Recent Trades:

  • President and CEO Amit Munshi sold 14,877 shares of ARNA stock on 01/12/2021 at the average price of $75.12. The price of the stock has increased by 7.24% since.

For the complete insider trading history of ARNA, click here

.This article first appeared on GuruFocus.